Affymetrix Inc. (Nasdaq:AFFX) announced today that the Autism Consortium has selected the single Affymetrix GeneChip(R) Human Mapping 500K Array for the world’s most comprehensive study on the genes associated with autism. The Autism Gene Discovery Project will be conducted by scientific experts from the Autism Consortium and the Broad Institute of MIT and Harvard. The researchers will use the 500K Array to perform whole-genome association studies across 3,700 samples collected from autistic subjects.
